Man Group’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$162K Buy
2022
Q4
Sell
2022
Q3
$18K Buy
2022
Q2
Hold
2020
Q1
Sell
2019
Q4
$315K Hold
2019
Q3
$317K Sell
2019
Q2
$628K Buy
2019
Q1
$725K Sell
2018
Q4
$932K Sell
2018
Q3
$2.87M Sell
2018
Q2
$3.44M Buy